Dr. Alexandru Topliceanu, MD

Dr. Topliceanu practices at INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health.

Dr. Topliceanu's NPI, 1366728768, was assigned on October 30, 2011. Dr. Topliceanu holds Oklahoma license 32796.

Dr. Topliceanu's primary practice is INTEGRIS Health Baptist Medical Center, at 3300 Northwest Expressway, Oklahoma City, OK 73112 in Oklahoma County. The practice phone is (405) 949-3011.

Dr. Topliceanu's primary practice is INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health. Dr. Topliceanu is also affiliated with INTEGRIS Health Southwest Medical Center. The medical group on file is INTEGRIS Health Cardiovascular Physicians. Dmand AI also links Dr. Topliceanu to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Topliceanu practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Topliceanu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Topliceanu is licensed in Oklahoma.

CMS data shows 4,050 Medicare services from Dr. Topliceanu across 25 procedure codes in 2024, for 2,458 Medicare patients. Medicare paid $135,048 for them.

CMS counts 2,458 Medicare patients who saw Dr. Topliceanu in 2024. The largest group is 65 to 74, with 947 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Topliceanu's median patient age at 68, with 55% women.

In 2024, Dr. Topliceanu wrote 4,405 Medicare Part D claims for 568 patients. 77% of them were for generic drugs. CMS names the drug for 4,143 of them, across 48 drugs with 11 or more claims each, at $887,436 in total drug cost. In 2023, CMS named 3,316 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Topliceanu for performance year 2024, reported as part of a group. Dr. Topliceanu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Topliceanu as offering telehealth.

CMS Open Payments shows 37 general payments to Dr. Topliceanu from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $227.